Immunogenicity of 23-valent pneumococcal polysaccharide vaccine in HIV-infected pregnant women and kinetics of passively acquired antibodies in young infants

被引：20

作者：

Almeida, Volia De Carvalho ^{[1
]}

Mussi-Pinhata, Marisa Marcia ^{[2
]}

Sandoval De Souza, Cleonice Barbosa ^{[2
]}

Kubo, Christina Arslanian ^{[3
]}

Martinez, Edson Zangiacomi ^{[4
]}

Carneiro-Sampaio, Magda Maria ^{[5
]}

Duarte, Geraldo ^{[6
]}

机构：

[1] Univ Fed Sao Carlos, Biol & Hlth Sci Ctr, Dept Med, BR-13565905 Sao Carlos, SP, Brazil

[2] Univ Sao Paulo, Dept Pediat, Fac Med Ribeirao Preto, BR-14049900 Ribeirao Preto, SP, Brazil

[3] Univ Sao Paulo, Dept Immunol, Inst Biomed Sci, BR-05508900 Sao Paulo, Brazil

[4] Univ Sao Paulo, Dept Social Med, Fac Med Ribeirao Preto, BR-14049900 Ribeirao Preto, SP, Brazil

[5] Univ Sao Paulo, Dept Pediat, Fac Med, BR-05403900 Sao Paulo, Brazil

[6] Univ Sao Paulo, Dept Gynecol & Obstet, Fac Med Ribeirao Preto, BR-14049900 Ribeirao Preto, SP, Brazil

来源：

VACCINE | 2009年 / 27卷 / 29期

基金：

巴西圣保罗研究基金会;

关键词：

Pneumococcal polysaccharide vaccine; HIV-infected pregnant woman; Passively acquired pneumococcal antibodies; MATERNAL IMMUNIZATION; STREPTOCOCCUS-PNEUMONIAE; PLACENTAL-TRANSFER; 22F POLYSACCHARIDE; CONJUGATE VACCINE; VIRAL LOAD; SERUM IGG; DISEASE; ADULTS; TRANSMISSION;

D O I：

10.1016/j.vaccine.2009.04.018

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Whether gestational immunization of HIV-infected mothers with the 23-valent pneumococcal polysaccharide vaccine (PPV) confers maternal and infant early life, passive protection is not known. We evaluated safety, immunogenicity and placental transfer of antibodies in 44 HIV-infected women. Pneumococcal IgG antibodies against serotypes 1, 3, 5, 613, 9V, and 14 were measured in mothers (pre-vaccination and at delivery), and infants (at birth, 1, 2, 3, and 6 months). PPV was safe and immunogenic in mothers. Newborns received 46-72% of maternal antibody titers. Overall, infants had antibody levels lower than protective by 2 months of age. Alternative pneumococcal vaccination of HIV-infected pregnant women should be explored with the aim of prolonging passive protection in their infants. (C) 2009 Elsevier Ltd. All rights reserved.

引用

页码：3856 / 3861

页数：6

共 50 条

[21] The Immunogenicity of 7-Valent Pneumococcal Conjugate Vaccine versus 23-Valent Polysaccharide Vaccine in Adults Aged 50-80 Years [J].

Goldblatt, David ;

Southern, Jo ;

Andrews, Nick ;

Ashton, Lindsey ;

Burbidge, Polly ;

Woodgate, Sarah ;

Pebody, Richard ;

Miller, Elizabeth .

CLINICAL INFECTIOUS DISEASES, 2009, 49 (09) :1318-1325

[22] A Randomized Clinical Trial of the Immunogenicity of 7-Valent Pneumococcal Conjugate Vaccine Compared to 23-Valent Polysaccharide Vaccine in Frail, Hospitalized Elderly [J].

MacIntyre, C. Raina ;

Ridda, Iman ;

Gao, Zhanhai ;

Moa, Aye M. ;

McIntyre, Peter B. ;

Sullivan, John S. ;

Jones, Thomas R. ;

Hayen, Andrew ;

Lindley, Richard I. .

PLOS ONE, 2014, 9 (04)

[23] Immunogenicity of a 23-valent pneumococcal polysaccharide vaccine in elderly residents of a long-term care facility [J].

Valenzuela B., M. Teresa ;

Altuzarra H., Rogelio ;

Trucco A., Olivia ;

Villegas R., Rodrigo ;

Inostroza S., Jaime ;

Granata S., Paulo ;

Fleiderman V., Jose ;

Maggi C., Leonardo .

BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2007, 11 (03) :322-326

[24] IMMUNOGENICITY AND SAFETY OF A 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE IN HEALTHY-CHILDREN AND IN CHILDREN AT INCREASED RISK OF PNEUMOCOCCAL INFECTION [J].

LEE, HJ ;

KANG, JH ;

HENRICHSEN, J ;

KONRADSEN, HB ;

JANG, SH ;

SHIN, HY ;

AHN, HS ;

CHOI, Y ;

HESSEL, L ;

NAM, SW .

VACCINE, 1995, 13 (16) :1533-1538

[25] Immunogenicity following the first and second doses of 7-valent pneumococcal conjugate vaccine in HIV-infected and -uninfected infants [J].

Madhi, Shabir A. ;

Izu, Alane ;

Violari, Avye ;

Cotton, Mark F. ;

Panchia, Ravindre ;

Dobbels, Els ;

Sewraj, Poonam ;

van Niekerk, Nadia ;

Jean-Philippe, Patrick ;

Adrian, Peter V. .

VACCINE, 2013, 31 (05) :777-783

[26] Immunogenicity of a combined schedule of 7-valent pneumococcal conjugate vaccine followed by a 23-valent polysaccharide vaccine in adult recipients of heart or lung transplants [J].

Gattringer, R. ;

Winkler, H. ;

Roedler, S. ;

Jaksch, P. ;

Herkner, H. ;

Burgmann, H. .

TRANSPLANT INFECTIOUS DISEASE, 2011, 13 (05) :540-544

[27] Immunogenicity and safety after the third vaccination with the 23-valent pneumococcal polysaccharide vaccine in elderly patients with chronic lung disease [J].

Ohshima, Nobuharu ;

Akeda, Yukihiro ;

Nagai, Hideaki ;

Oishi, Kazunori .

HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2020, 16 (09) :2285-2291

[28] Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine compared to 23-valent pneumococcal polysaccharide in immunocompetent adults: A systematic review and meta-analysis [J].

Vadlamudi, Nirma Khatri ;

Parhar, Kamalpreet ;

Malana, Kim Lorenzo Altre ;

Kang, Amy ;

Marra, Fawziah .

VACCINE, 2019, 37 (08) :1021-1029

[29] Safety and immunogenicity of the 23-valent pneumococcal polysaccharide vaccine at 12 months of age, following one, two, or three doses of the 7-valent pneumococcal conjugate vaccine in infancy [J].

Russell, F. M. ;

Licciardi, P. V. ;

Balloch, A. ;

Biaukula, V. ;

Tikoduadua, L. ;

Carapetis, J. R. ;

Nelson, J. ;

Jenney, A. W. J. ;

Waqatakirewa, L. ;

Colquhoun, S. ;

Cheung, Y. B. ;

Tang, M. L. K. ;

Mulholland, E. K. .

VACCINE, 2010, 28 (18) :3086-3094

[30] Immunogenicity and safety of concomitant MF59-adjuvanted influenza vaccine and 23-valent pneumococcal polysaccharide vaccine administration in older adults [J].

Song, Joon Young ;

Cheong, Hee Jin ;

Tsai, T. F. ;

Chang, Hyun-ah ;

Choi, Min Joo ;

Jeon, Ji Ho ;

Kang, Seong Hee ;

Jeong, Eun Ju ;

Noh, Ji Yun ;

Kim, Woo Joo .

VACCINE, 2015, 33 (36) :4647-4652

← 1 2 3 4 5 →